Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludrocortisone and midodrine for orthostatic hypotension
ISRCTN87213295Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of fludrocortisone and midodrine in orthostatic hypotension (OH) (3 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Change in Orthostatic Hypotension Questionnaire score. Started Jul 2021; status: completed.
02
Drugs
fludrocortisonemidodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on ISRCTN87213295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87213295.